Postherpetic Neuralgia
📧 Sign up to get email alerts when something new happens for Postherpetic Neuralgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-03-08FDA Approved: PREGABALIN — Original Application (Eskayef Pharmaceuticals Limited)
FDA approved Eskayef Pharmaceuticals Limited's original application for generic pregabalin (ANDA212988).
-
FDA approval · 2022-02-18FDA Approved: PREGABALIN — Original Application (Patrin Pharma, Inc.)
FDA approved an original application for pregabalin from Patrin Pharma, making a generic version available. This marks the approval of a gen…
-
FDA approval · 2021-10-15FDA Approved: GABAPENTIN — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for gabapentin from Quallent Pharmaceuticals Health LLC, resulting in the approval of their generic …
-
FDA approval · 2021-10-01FDA Approved: GABAPENTIN — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved the original ANDA for gabapentin from XLCare Pharmaceuticals, enabling a generic version of the anticonvulsant.
-
FDA approval · 2021-09-29FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (AiPing Pharmaceutical, Inc.)
FDA approved a supplemental application for Amitriptyline Hydrochloride, a generic product submitted by AiPing Pharmaceutical, Inc., under t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-09-16FDA Approved: GRALISE — Supplemental Application (Almatica Pharma LLC)
FDA approves a supplemental application for Gralise (gabapentin) submitted by Almatica Pharma LLC.
-
FDA approval · 2021-08-05FDA Approved: QUTENZA — Supplemental Application (Averitas Pharma Inc)
FDA approved a supplemental application for QUTENZA (capsaicin) from Averitas Pharma Inc.
-
FDA approval · 2021-07-15FDA Approved: PREGABALIN — Original Application (Tris Pharma Inc)
The FDA approved Tris Pharma's original Abbreviated New Drug Application for pregabalin, allowing a generic pregabalin product to enter the …
-
FDA approval · 2021-05-10FDA Approved: GABAPENTIN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic gabapentin under an Original Application (ANDA 214956); the product is indicated for partial se…
-
FDA approval · 2021-04-26FDA Approved: GABAPENTIN — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Gabapentin from Actavis Pharma, Inc., enabling the generic product to reach the market.
-
FDA approval · 2021-04-13FDA Approved: PREGABALIN — Original Application (Novadoz Pharmaceuticals LLC)
FDA approves the original abbreviated new drug application for pregabalin from Novadoz Pharmaceuticals LLC, enabling a generic version of pr…
-
FDA approval · 2021-03-05FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc)
FDA approved Granules Pharmaceuticals Inc's supplemental application for gabapentin granules, approving a new granulated formulation of a ge…
-
FDA approval · 2020-12-16FDA Approved: NEURONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for Neurontin (gabapentin) submitted by Parke-Davis Div of Pfizer Inc. The action pertains to labeli…
-
FDA approval · 2020-12-16FDA Approved: NEURONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Neurontin (gabapentin) submitted by Parke-Davis Division of Pfizer Inc, indicating a change …
-
FDA approval · 2020-10-27FDA Approved: GABAPENTIN — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for gabapentin from BluePoint Laboratories under an ANDA.
-
FDA approval · 2020-10-19FDA Approved: GABAPENTIN — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for gabapentin from Quallent Pharmaceuticals Health LLC. The approval may modify labeling or indicat…
-
FDA approval · 2020-09-29FDA Approved: GABAPENTIN — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Gabapentin from ScieGen Pharmaceuticals, Inc.
-
FDA approval · 2020-09-16FDA Approved: GABAPENTIN — Supplemental Application (ACI Healthcare USA, Inc.)
FDA approved a supplemental application for gabapentin from ACI Healthcare USA, Inc., updating the regulatory status of the product.
-
FDA approval · 2020-09-08FDA Approved: GABAPENTIN — Supplemental Application (Exelan Pharmaceuticals, Inc.)
FDA approved a supplemental application for gabapentin from Exelan Pharmaceuticals, Inc. under an ANDA.
-
FDA approval · 2020-08-21FDA Approved: GABAPENTIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for gabapentin from Amneal Pharmaceuticals LLC.
-
FDA approval · 2020-08-17FDA Approved: GABAPENTIN — Original Application (Zhejiang Yongtai Pharmaceutical Co., Ltd)
FDA approved the original application for gabapentin from Zhejiang Yongtai Pharmaceutical Co., Ltd., authorizing a generic gabapentin produc…
-
FDA approval · 2020-08-07FDA Approved: GABAPENTIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for gabapentin from Sun Pharmaceutical Industries, Inc., granting supplemental approval for this…
-
FDA approval · 2020-07-28FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc)
FDA approved a supplemental application for gabapentin submitted by Granules Pharmaceuticals Inc.
-
FDA approval · 2020-04-17FDA Approved: HORIZANT — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
The FDA approved a supplemental application for Horizant (gabapentin enacarbil) submitted by Azurity Pharmaceuticals (formerly Arbor Pharmac…
-
FDA approval · 2020-04-03FDA Approved: LYRICA CR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental NDA for LYRICA CR (pregabalin) submitted by Viatris Specialty LLC, indicating a regulatory approval of a supplem…